Curtiss-Wright’s Q3 2026 earnings call: our top 5 analyst questions

Curtiss-Wright reported Q3 2026 revenue of $953M, beating estimates, with adjusted EPS of $3.94. The company raised full-year revenue and EPS guidance. Management highlighted strong order growth in defense and naval segments, but margins faced pressure due to R&D investments. The stock is currently trading at $433.75, down from pre-earnings levels.

Original reporting
Published Nov 6, 2026, 6:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2026, 12:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Curtiss-Wright’s Q3 2026 earnings call: our top 5 analyst questions — source image
Decision brief

The 30-second read

$CWBullishMed
01

Why it matters

The earnings beat and raised guidance provide a fresh catalyst for traders, especially those focused on defense and industrial sectors.

02

Market read

The earnings release is a primary disclosure for a mid‑cap industrial stock, offering a clear trading signal.

03

What to watch

Potential budget delays in defense spending and regulatory hurdles for nuclear projects could temper growth.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Curtiss‑Wright is a diversified industrial company with aerospace, defense, and nuclear businesses. The Q3 2026 earnings call highlighted strong order growth and a modest market reaction.

Company-level read

Ticker impact

$CWBullishHigh confidence
Context

Curtiss‑Wright reported Q3 2026 results with revenue beat, EPS beat and raised full‑year guidance.

Expected impact

likely upward pressure as the market prices in the guidance lift

Evidence & confidence

The company beat both revenue and EPS estimates and increased its FY revenue and EPS outlook, which typically supports a price rally.

Market effects

Defense electronics and commercial nuclear segments may see broader investor interest.

U.S. defense and industrial investors could see modest inflows.

International markets may react to the strong order book and backlog guidance.

Counterpoint

If margin pressure from higher R&D spend persists, the stock could face downside despite the beat.

Key entities

  • Curtiss‑Wright

    Industrial manufacturer with aerospace, defense, and nuclear segments.

  • Lynn Bamford

    CEO of Curtiss‑Wright who commented on backlog and growth.

Related articles

$LMTMed

Defense Watch: Strong Q3 Earnings, New Military Contracts, But Democrats’ Sweep Poses Spending Hurdles — TradingView News

U.S. defense contractors reported Q3 earnings growth and secured new contracts, but Democratic election wins raised concerns over military spending. Curtiss-Wright (CW) reported 10% revenue growth and raised its 2026 EPS forecast. Leidos (LDOS) and BWX Technologies (BWXT) also posted earnings. Lockheed Martin (LMT), Boeing (BA), and others won multi-million-dollar contracts. Defense stocks fell, with CW, LDOS, and BWXT down 21%, 26%, and 30% YTD.

$LMTMed

Defense Watch: Strong Q3 Earnings, New Military Contracts, But Democrats’ Sweep Poses Spending Hurdles

Lockheed Martin, Boeing, and Curtiss-Wright secured U.S. Navy contracts. Leonardo DRS partnered with AeroVironment for anti-drone lasers. Democrats' midterm wins may impact Trump's $1.5T 2027 defense budget. Defense stocks like LMT, LHX, RTX, and NOC fell. L3Harris, Boeing, and HII reported strong Q3 earnings. Curtiss-Wright (CW) raised its 2026 EPS forecast after a 10% revenue increase and $1.1B in new orders. Leidos (LDOS) beat EPS estimates but missed revenue forecasts.

$CWMed

Curtiss-Wright Corp (CW) (Q3 2026) Earnings Call Highlights: Record Backlog and Raised

Curtiss-Wright Corp (CW) reported Q3 2026 earnings with record backlog and raised guidance. Defense Electronics sales grew 2% but margins declined due to mix. Q4 revenue is expected to increase, though supply chain pressures and leadership transitions pose risks. The AP1000 reactor coolant pump order timing remains uncertain. The company is optimistic about its pipeline and supply chain management.

$CWMed

Curtiss-Wright (CW) Q3 2026 Earnings Call Transcript

Curtiss-Wright (CW) reported Q3 2026 sales of $953M, up 10% YoY, with EPS of $3.94, up 16%. The company raised full-year guidance, projecting 8-10% sales growth and 16-18% EPS growth. Free cash flow was $160M, with a 108% conversion rate. New orders increased 15%, and the backlog reached a record $4.6B. Leadership transitions include Kevin Rayment becoming CEO and Gary A. Ogilby serving as Interim CFO.